Related references
Note: Only part of the references are listed.Long-term polyclonal and multilineage engraftment of methylguanine methyltransferase P140K gene-modified dog hematopoietic cells in primary and secondary recipients
Brian C. Beard et al.
BLOOD (2009)
Busulfan in hematopoietic stem cell transplant setting
Jeannine S. McCune et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency.
Alessandro Aiuti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Nathalie Cartier et al.
SCIENCE (2009)
Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors
Grant D. Trobridge et al.
BLOOD (2008)
Stem Cell Engineering for the Treatment of Severe Hemoglobinopathies
Michel Sadelain et al.
CURRENT MOLECULAR MEDICINE (2008)
Efficient entry inhibition of human and nonhuman primate immunodeficiency virus by cell surface-expressed gp41-derived peptides
R. C. Zahn et al.
GENE THERAPY (2008)
Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors:: A children's oncology group study
Denise M. Adams et al.
PEDIATRIC BLOOD & CANCER (2008)
Phase I trial of single-dose temozolomide and continuous administration of O6-benzylguanine in children with brain tumors:: a Pediatric Brain Tumor Consortium report
Alberto Broniscer et al.
CLINICAL CANCER RESEARCH (2007)
Triazene compounds: Mechanism of action and related DNA repair systems
Francesco Marchesia et al.
PHARMACOLOGICAL RESEARCH (2007)
Chemoradiotherapy in malignant glioma: Standard of care and future directions
Roger Stupp et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells
Brian C. Beard et al.
MOLECULAR THERAPY (2007)
Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus
Brian C. Beard et al.
HUMAN GENE THERAPY (2007)
In vivo selection and chemoprotection after drug resistance gene therapy in a nonmyeloablative allogeneic transplantation setting in dogs
Sabine Gerull et al.
HUMAN GENE THERAPY (2007)
Foamy virus-mediated gene transfer to canine repopulating cells
Hans-Peter Kiem et al.
BLOOD (2007)
Efficient transduction and engraftment of G-CSF-mobilized peripheral blood CD34+ cells in nonhuman primates using GALV-pseudotyped gammaretroviral vectors
Brian C. Beard et al.
MOLECULAR THERAPY (2006)
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
MG Ott et al.
NATURE MEDICINE (2006)
Survival of the fittest: in vivo selection and stem cell gene therapy
T Neff et al.
BLOOD (2006)
Busulfan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model
EM Kang et al.
EXPERIMENTAL HEMATOLOGY (2006)
Foamy virus vector integration sites in normal human cells
GD Trobridge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma
JA Quinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy
T Neff et al.
BLOOD (2005)
Identifying protein function - A call for community action
RJ Roberts
PLOS BIOLOGY (2004)
Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease
LS Kean et al.
BLOOD (2003)
Transcription start regions in the human genome are favored targets for MLV integration
XL Wu et al.
SCIENCE (2003)
Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model
T Neff et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The transplantation of hematopoietic stem cells after non-myeloablative conditioning - A cellular therapeutic approach to hematologic and genetic diseases
M Maris et al.
IMMUNOLOGIC RESEARCH (2003)
Highly efficient gene transfer into baboon marrow repopulating cells using GALU pseudotype oncoretroviral vectors produced by human packaging cells
PA Horn et al.
BLOOD (2002)
Polyclonal long-term repopulating stem cell clones in a primate model
M Schmidt et al.
BLOOD (2002)
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gene therapy in infants with severe combined immunodeficiency
M Otsu et al.
BIODRUGS (2002)
Sustained multilineage gene persistence and expression in dogs transplanted with CD34+ marrow cells transduced by RD114-pseudotype oncoretrovirus vectors
M Goerner et al.
BLOOD (2001)
Applied molecular evolution of O6-benzylguanine-resistant DNA alkyltransferases in human hematopoietic cells
BM Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Pulmonary drug toxicity: Radiologic and pathologic manifestations
SE Rossi et al.
RADIOGRAPHICS (2000)